Shelton Wealth Management, LLC Abb Vie Inc. Transaction History

Shelton Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $8,745 - $10,883	66 Added 2.76%	2,457 $331,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $91,971 - $105,919	636 Added 36.24%	2,391 $381,000
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $13,139 - $15,757	95 Added 5.72%	1,755 $283,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $222,788 - $255,523	1,660 New	1,660 $223,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Shelton Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Shelton Wealth Management, LLC with notifications on news.